Evidence map›Paper›PMID 35513576›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2022

Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD.

Catherine L Shelton, Kathleen M Meneely, Trey A Ronnebaum, Annemarie S Chilton, Andrew P Riley, Thomas E Prisinzano, Audrey L Lamb

Open access · hybridAbstract read
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Relationship between Pyochelin andInternational journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Catherine L SheltonDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Kathleen M MeneelyDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Trey A RonnebaumDepartment of Chemistry, University of Kansas, Lawrence, KS, 66045, USA.
Annemarie S ChiltonDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Andrew P RileyDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Thomas E PrisinzanoDepartment of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, 66045, USA.
Audrey L LambDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA. audrey.lamb@utsa.edu.ORCID 0000-0002-2352-2130
University of Kansas · USUniversity of Kentucky · US

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
U of Kansas/Haskell Indian Nations U.IRACDA ProjectK12GM063651 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI DE GUZMAN, ROBERTO N · 2002 to 2022
$10.0M
Institutional Career DevelopmentKL2TR002002 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PHILLIPS, SHANE A · 2016 to 2024
$6.8M
TRAINING GRANT IN DYNAMIC ASPECTS OF CHEMICAL BIOLOGYT32GM008545 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 1994 to 2019
$4.9M
Novel and essential metallophores from multidrug resistant bacterial pathogensR01GM127655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI LAMB, AUDREY L · 2018 to 2020
$910k
Understanding Oligomer Assembly of Isoprenoid and Terpene SynthasesF32GM137461 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI RONNEBAUM, TREY ADAM · 2021 to 2022
$77k
Division of Chemistry 1904494Division of Chemistry 2041047NCATS NIH HHS KL2 TR002002NIGMS NIH HHS F32 GM137461NIGMS NIH HHS K12 GM063651NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20 GM113117NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM127655NIGMS NIH HHS T32 GM008545
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an increasingly antibiotic-resistant pathogen that causes severe lung infections, burn wound infections, and diabetic foot infections. P. aeruginosa produces the siderophore pyochelin through the use of a non-ribosomal peptide synthetase (NRPS) biosynthetic pathway. Targeting members of siderophore NRPS proteins is one avenue currently under investigation for the development of new antibiotics against antibiotic-resistant organisms. Here, the crystal structure of the pyochelin adenylation domain PchD is reported. The structure was solved to 2.11 Å when co-crystallized with the adenylation inhibitor 5'-O-(N-salicylsulfamoyl)adenosine (salicyl-AMS) and to 1.69 Å with a modified version of salicyl-AMS designed to target an active site cysteine (4-cyano-salicyl-AMS). In the structures, PchD adopts the adenylation conformation, similar to that reported for AB3403 from Acinetobacter baumannii.

Indexed as

Pseudomonas aeruginosaSiderophoresAnti-Bacterial AgentsPhenolsSalicylatesThiazolesAnti-Bacterial AgentsPhenolspyochelinSalicylatesSiderophoresThiazolesAdenylation domainAntibiotic resistanceInhibitor designPseudomonas aeruginosaPyochelin

Identifiers

PMID35513576
PMCPMC9470617
OpenAlexW4229015695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.